World Biosimilar Congress San Diego USA 2018
Bringing together the most prominent names in biosimilars, World Biosimilar Congress USA has become the staple event for stakeholders to gather and address the current and future state of the biosimilars.
Join 300+ industry colleagues in San Diego, CA this May 23-24, 2018 for the largest and most comprehensive meeting yet.
In 2018, the event will focus both on the business and scientific ends of the biosimilar value chain- making it the only meeting of its kind.
Hear from 150+ biosimilar experts from companies such as: Sandoz, Amgen, Samsung Bioepis, Mylan, UIC, Wockhardt, Polpharma, AstraZeneca, Teva, Cinfa, Sanofi, Medicaid Health Plans of America, Plant Form, Intas, Humana, Kaiser Permanente, and more.
Wondering who attends?
• 50% pharma/ biotech/ associations
• 30% payers/ patients/ agency
• 20% vendors /solutions providers
For more information, download the brochure >>
Don’t miss this opportunity to learn from and do business with hundreds of industry colleagues at the World Biosimilar Congress and help find the answers to shape the future of US healthcare!
Book now to ensure the best price. Register now >>